WHEN Mark Lashway found out that his melanoma skin cancer had spread to his lungs, he immediately quit his job as a chemistry teacher in Hillsdale, New York, and prepared for the worst. “I knew the survival rate was only 15 per cent and I was frightened. It was the realisation of like, ‘Holy cow, is this it?’,” he says.
Original article: https://www.newscientist.com/article/mg25433920-400-personalised-cancer-vaccines-are-finally-beating-hard-to-treat-tumou
